adapalene
Selected indexed studies
- Adapalene. (, 2006) [PMID:30000483]
- Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris. (Eur J Dermatol, 2022) [PMID:36301750]
- Spotlight on adapalene. (Expert Opin Drug Metab Toxicol, 2009) [PMID:19929446]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Adapalene. (2006) pubmed
- Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris. (2022) pubmed
- Spotlight on adapalene. (2009) pubmed
- Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug. (2022) pubmed
- Differin (adapalene) Gel, 0.3%. (2007) pubmed
- Recent Advances Regarding the Therapeutic Potential of Adapalene. (2020) pubmed
- Adapalene as an anticancer agent: A systematic review and meta-analysis of in vitro and in vivo studies. (2025) pubmed
- Managing acne vulgaris: an update. (2023) pubmed
- Adapalene, a new chemical entity with retinoid activity. (1993) pubmed
- Adapalene: a review of its use in the treatment of acne vulgaris. (2004) pubmed